H. Heijerman (The Hague, The Netherlands), F. Ratjen (Essen, Germany)
High transfection efficiency and sustained transgene expression in rat lung
R. A. Schmid, B. Kubisa, E. Ayuni, M. Checchini, A. Wetterwald, J. Glasspool, R. McDonald, S. C. Hyde, T. Geiser, R. W. Malone (Bern, Switzerland; Rockville, Davis, United States Of America; Oxford, United Kingdom)
|  |
Prevalence of mannose-binding lectin variant alleles among cystic fibrosis patients in Italy
F. Cardinale, A. Polizzi, T. Santostasi, A. Manca, G. Iacoviello, R. Francavilla, F. De Robertis, A. Calò, R. Cavallone, I. Chinellato, M. S. Loffredo, N. Rigillo, L. Armenio (Bari, Italy)
| |
Oral L-arginine therapy in patients with cystic fibrosis: a pilot study
H. Grasemann, K. Sroka, W. H. Nikolaizik, F. Ratjen (Essen, Germany)
| |
Intestinal current measurement (ICM) as a diagnostic tool for atypical cystic fibrosis
M. Ballmann, N. Derichs, F. Mekus, B. Tuemmler (Hannover, Germany)
| |
The changing epidemiology of cystic fibrosis in Italy: data from the Italian registry
R. Padoan, L. Viviani, L. Giglio, A. Bossi (Milan, Trieste, Italy)
| |
DNA-based screening for CF: which protocol is best in a multiethnic Europe? Lessons from the UK experience
J. McCormick, M. W. Green, G. Mehta, F. Culross, A. Mehta (Dundee, United Kingdom)
| |
Screening for cystic fibrosis among high risk group patients with chronic lung disease
R. M. Shawky, K. A. A. Khalik, S. M. A Fattah, S. S. El Moselhy, M. M. Rifaat, M. R. A. Hassan (Cairo, Egypt)
| |
Sweat chloride concentration less then 60 meq/l does not exclude the diagnosis of cystic fibrosis (CF): analysis of 6 patients
A. E. Alvarez, A. F. Ribeiro, G. Hessel, C. S. Bertuzzo, J. D. Ribeiro (Campinas, Brazil)
| |
Cystic fibrosis (CF) in the last decade of the twentieth century in Brazil - clinical and laboratorial characteristics of 104 patients
A. E. Alvarez, A. F. Ribeiro, G. Hessel, C. S. Bertuzzo, J. D. Ribeiro (Campinas, Brazil)
| |
Portrait of the cystic fibrosis (CF) patient in Australia and New Zealand (NZ) in 1999
P. Cooper, K. McKay, Z. Bobosevich, S. Bell (Sydney, North Ryde, Brisbane, Australia)
| |
Analysis of relationship between Nasal Potential Difference, genotype and clinical phenotype in patients with cystic fibrosis
E. N. Mitkina, T. E. Gembitskaia, M. A. Zaitseva, L. A. Jelenina, T. S. Sologub (St-Petersburg, Russia)
| |
Pediatric mucoceles in cystic fibrosis treated with ESS (endoscopic sinus surgery)
M. Di Cicco, A. Bassotti, D. Costantini, R. Padoan (Milan, Italy)
| |
Increased priming of blood neutrophils in children with clinically stable cystic fibrosis
S. W. Terheggen, G. T. Rijkers, L. Koenderman, J. W. J. Lammers, C. K. van der Ent (Utrecht, The Netherlands)
| |
Prevalence of thrombophilia and catheter-related events in cystic fibrosis
M. Barker, D. Thoenes, C. Pfannenstiel, H. Doehmen, F. Friedrichs, M. Buchenroth, G. Heimann (Aachen, Aachen-Laurensberg, Germany)
| |
DeltaF508 genotype for cystic fibrosis is significantly associated with reduced bone mineral density (BMD) in adults with CF
S. J. King, D. J. Topliss, T. Kotsimbos, I. B. Nyulasi, M. Bailey, J. W. Wilson (Melbourne, Australia)
| |
Improvement in pulmonary function after IV antibiotic treatment in cystic fibrosis patients
G. Pisi, G. Grzincich, C. Spaggiari, G. Attanasi, R. Marvasi, A. Battistini (Parma, Italy)
| |
Quality of life in children with cystic fibrosis and asthma
E. Hatziagorou, P. Karagianni, A. Vidalis, M. Bullinger, J. Tsanakas (Thessaloniki, Greece; Hamburg-Eppendorf, Germany)
| |
Association of clinical variables in children with cystic fibrosis and health-related quality of life
P. Karagianni, E. Hatziagorou, A. Vidalis, M. Bullinger, J. Tsanakas (Thessaloniki, Greece; Hamburg-Eppendorf, Germany)
| |
Quality of life in cystic fibrosis patients before and after lung transplantation: a longitudinal study
K. M. Vermeulen, W. van der Bij, M. E. Erasmus, G. H. Koëter, E. M. TenVergert (Groningen, The Netherlands)
| |